feed,title,long_url,short_url
Benzinga,Bluebird Bio's Shares Drop To 52-Week Low After Another Gene Therapy Trial Placed On FDA Hold,https://benzinga.com/general/biotech/21/08/22402020/bluebird-bios-shares-drop-to-52-week-low-after-another-gene-therapy-trial-placed-on-fda-hold,https://j.mp/3s1xH6Q
